Roberts DM, et al. Clinical pharmacokinetics in kidney disease: Application to rational design of dosing regimens. Clin J Am Soc Nephrol 2018; 13:1254–1263. doi: 10.2215/CJN.05150418
Morrissey KM, et al. Renal transporters in drug development. Annu Rev Pharmacol Toxicol 2013; 53:503–529. doi: 10.1146/annurev-pharmtox-011112-140317
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024; 105:S117–S314. doi: 10.1016/j.kint.2023.10.018
Davison SN. Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clin J Am Soc Nephrol 2019; 14:917–931. doi: 10.2215/CJN.05180418
Wolf E, et al. Baclofen toxicity in kidney disease. Am J Kidney Dis 2018; 71:275–280. doi: 10.1053/j.ajkd.2017.07.005
Boschung-Pasquier L, et al. Cefepime neurotoxicity: Thresholds and risk factors. A retrospective cohort study. Clin Microbiol Infect 2020; 26:333–339. doi: 10.1016/j.cmi.2019.06.028
Behal ML, et al. Medication management in the critically ill patient with acute kidney injury. Clin J Am Soc Nephrol 2023; 18:1080–1088. doi: 10.2215/CJN.0000000000000101
Vilay AM, et al. Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. Crit Care 2008; 12:235. doi: 10.1186/cc7093
Crass RL, et al. Renal dosing of antibiotics: Are we jumping the gun? Clin Infect Dis 2019; 68:1596–1602. doi: 10.1093/cid/ciy790
Chawla LS, et al.; Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 2017; 13:241–257. doi: 10.1038/nrneph.2017.2
Haines RW, et al. Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness. Clin J Am Soc Nephrol 2023; 18:997–1005. doi: 10.2215/CJN.0000000000000203
Bilbao-Meseguer I, et al. Augmented renal clearance in critically ill patients: A systematic review. Clin Pharmacokinet 2018; 57:1107–1121. doi: 10.1007/s40262-018-0636-7
Jang SM, Awdishu L. Drug dosing considerations in continuous renal replacement therapy. Semin Dial 2021; 34:480–488. doi: 10.1111/sdi.12972
Kintzel PE, et al. Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher 2003; 18:194–205. doi: 10.1002/jca.10074